SRTS Stock Analysis: Buy, Sell, or Hold?
SRTS - Sensus Healthcare, Inc
$3.51
-0.10 (-2.77%)
▼
5d:
+2.93%
30d:
-21.83%
90d:
-8.36%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Accumulation
SRTS is down 12.2% this week, but smart money is accumulating calls. Top strike: $3 2026-07-17 with 366 OI. Call ratio: 64% View Scanner →
Strength: 7.5/10
Get Alerted When SRTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SRTS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SRTS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: SRTS is currently trading at $3.51, which is considered oversold relative to its 30-day fair value range of $3.59 to $4.35. From a valuation perspective, the stock is trading at a discount (Forward PE: 40.1) compared to its historical average (207.3). Remarkably, the market is currently pricing in an annual earnings decline of 42.2% over the next few years. This pessimistic expectation contrasts with the company's recent 433.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SRTS is in a downtrend. Immediate support is located at $2.82, while resistance sits at $4.28.
Market Sentiment: SRTS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.25 (+73.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SRTS is in a downtrend. Immediate support is located at $2.82, while resistance sits at $4.28.
Market Sentiment: SRTS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.25 (+73.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.59 -
$4.35
Company Quality Score
52/100
(HOLD)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding SRTS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 31th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 73.1% below Wall St target ($6.25)
Trading Range Analysis
30-Day Trading Range
$3.59 -
$4.35
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.82
(23.3%)
Support & Resistance Levels
Support Level
$2.82
Resistance Level
$4.28
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
40.11
Wall Street Target
$6.25
(+73.1%)
Revenue Growth (YoY)
-62.2%
Earnings Growth (YoY)
433.3%
Profit Margin
-28.1%
Valuation Discount vs History
-42.2% cheaper
PE vs Historical
40.1 vs 207.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-42.2%
(market-implied from PE analysis)
1-Year Target
$3.25
(-10%)
2-Year Target
$2.92
(-19%)
3-Year Target
$2.63
(-27%)
3-Yr Target (if PE normalizes)
(PE: 40→207)
$13.60
(+277%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 40.1 to 207.3
Stabilization Target:
$18.66
(+416.8%)
PE Expansion Potential:
+416.8%
Share & Embed Analysis
Last updated: May 18, 2026 11:41 AM ET
Data refreshes hourly during market hours. Next update: 12:40 PM
Data refreshes hourly during market hours. Next update: 12:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Eric Sachetta
BUY
2000 shares
2026-02-24
Eric Sachetta
BUY
7000 shares
2025-11-21
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 55 HOLD |
Advanced SRTS Option Strategies
Professional options setups generated by AI based on today's SRTS price and gamma walls.
